Page last updated: 2024-10-19

thioctic acid and Adrenocortical Carcinoma

thioctic acid has been researched along with Adrenocortical Carcinoma in 1 studies

Thioctic Acid: An octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.

Adrenocortical Carcinoma: A malignant neoplasm of the ADRENAL CORTEX. Adrenocortical carcinomas are unencapsulated anaplastic (ANAPLASIA) masses sometimes exceeding 20 cm or 200 g. They are more likely to be functional than nonfunctional, and produce ADRENAL CORTEX HORMONES that may result in hypercortisolism (CUSHING SYNDROME); HYPERALDOSTERONISM; and/or VIRILISM.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Curcio, M1
Avena, P1
Cirillo, G1
Casaburi, I1
Spizzirri, UG1
Nicoletta, FP1
Iemma, F1
Pezzi, V1

Other Studies

1 other study available for thioctic acid and Adrenocortical Carcinoma

ArticleYear
Functional Albumin Nanoformulations to Fight Adrenocortical Carcinoma: a Redox-Responsive Approach.
    Pharmaceutical research, 2020, Feb-14, Volume: 37, Issue:3

    Topics: Adrenocortical Carcinoma; Albumins; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival;

2020